Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.

Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan-Capner P, Rush M, Miller E.

Lancet. 1995 Mar 4;345(8949):567-9.

PMID:
7619183
2.
3.

Use of the Australian Childhood Immunisation Register for vaccine safety data linkage.

Gold M, Dugdale S, Woodman RJ, McCaul KA.

Vaccine. 2010 Jun 11;28(26):4308-11. doi: 10.1016/j.vaccine.2010.04.021. Epub 2010 Apr 27.

PMID:
20430123
4.

Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines.

Rothstein EP, Bernstein HH, Glode MP, Laussucq S, Nonenmacher J, Long SS, Hackell JG.

Am J Dis Child. 1993 Aug;147(8):854-7.

PMID:
8394646
5.

Vaccines for measles, mumps and rubella in children.

Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C.

Cochrane Database Syst Rev. 2012 Feb 15;2:CD004407. doi: 10.1002/14651858.CD004407.pub3. Review.

PMID:
22336803
6.

Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children.

Miller E, Goldacre M, Pugh S, Colville A, Farrington P, Flower A, Nash J, MacFarlane L, Tettmar R.

Lancet. 1993 Apr 17;341(8851):979-82.

PMID:
8096942
7.

Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom.

Miller E, Andrews N, Stowe J, Grant A, Waight P, Taylor B.

Am J Epidemiol. 2007 Mar 15;165(6):704-9. Epub 2007 Jan 4.

9.

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine.

Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, DeStefano F, Chen RT, Immanuel V, Pearson JA, Vadheim CM, Rebolledo V, Christakis D, Benson PJ, Lewis N; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group.

N Engl J Med. 2001 Aug 30;345(9):656-61.

10.

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team.

Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler SC.

Pediatrics. 1997 Jun;99(6):765-73.

PMID:
9164767
11.
12.

Adverse events associated with MMR vaccines in Japan.

Kimura M, Kuno-Sakai H, Yamazaki S, Yamada A, Hishiyama M, Kamiya H, Ueda K, Murase T, Hirayama M, Oya A, Nozaki S, Murata R.

Acta Paediatr Jpn. 1996 Jun;38(3):205-11.

PMID:
8741307
13.

Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.

Dourado I, Cunha S, Teixeira MG, Farrington CP, Melo A, Lucena R, Barreto ML.

Am J Epidemiol. 2000 Mar 1;151(5):524-30.

14.

Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.

Deforest A, Long SS, Lischner HW, Girone JA, Clark JL, Srinivasan R, Maguire TG, Diamond SA, Schiller RP, Rothstein EP, et al.

Pediatrics. 1988 Feb;81(2):237-46.

PMID:
3340474
15.

Acute idiopathic thrombocytopenic purpura following combined vaccination against measles, mumps, and rubella.

Chang SK, Farrell DL, Dougan K, Kobayashi B.

J Am Board Fam Pract. 1996 Jan-Feb;9(1):53-5. No abstract available.

PMID:
8770810
16.

Risk of serious neurologic disease after immunization of young children in Britain and Ireland.

Ward KN, Bryant NJ, Andrews NJ, Bowley JS, Ohrling A, Verity CM, Ross EM, Miller E.

Pediatrics. 2007 Aug;120(2):314-21.

PMID:
17671057
17.

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.

Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K.

N Engl J Med. 1994 Nov 24;331(21):1397-402.

18.

Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Marin M, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12.

19.

Prophylactic paracetamol with childhood immunisation?

[No authors listed]

Drug Ther Bull. 1990 Sep 17;28(19):73-4. Review. No abstract available.

PMID:
2131221
20.

[Thrombocytopenic purpura after isolated or combined vaccination against measles, mumps and rubella].

Autret E, Jonville-Béra AP, Galy-Eyraud C, Hessel L.

Therapie. 1996 Nov-Dec;51(6):677-80. French.

PMID:
9164004
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk